Name of the fund//award/scholarship: | |
Application dates: | |
Who can apply: | |
Applicable for which country: | 5 |
How to apply: | |
Information: |
Name of the fund//award/scholarship: | Welander/Finsens research funds |
Application dates: | 2013-02-27 - 2013-03-31 |
Who can apply: | All Swedish dermato-venereologists |
Applicable for which country: | Sweden |
How to apply: | Visit the website http://hudfonden.se and make the application online |
Information: | http://hudfonden.se |
Name of the fund//award/scholarship: | Travel Grant for The 32th Nordic Congress in Tampere, Finland on August 18-20 2013 |
Application dates: | 2013-05-31 |
Who can apply: | All Nordic dermato-venereologists |
Applicable for which country: | Denmark, Finland, Iceland, Norway, Sweden |
How to apply: | Fill in the form and apply with your national Dermatology Society |
Information: | http://www.nordicdermatology.com/images/stories/NDATravelGrantsNordicCongress.pdf |
Name of the fund//award/scholarship: | Welander/Finsens research funds |
Application dates: | 2014-02-27 - 2014-03-31 |
Who can apply: | All Swedish dermato-venereologists |
Applicable for which country: | Sweden |
How to apply: | Visit the website http://hudfonden.se and make the application online |
Information: | http://hudfonden.se |
Name of the fund//award/scholarship: | La Fondation La Roche-Posay |
Application dates: | 2014-05-31 |
Who can apply: | Are you a dermatologist, born after January 1974, working in the field of dermatological research? Do your studies contribute to a better understanding and improved treatment of dermatological conditions, thus enhancing the quality of life of countless patients? If so, we invite you to submit your project to the Scientific Committee of the La Fondation La Roche-Posay. |
Applicable for which country: | Denmark, Finland, Iceland, Norway, Sweden |
How to apply: | Applications are limited to one per candidate.Only work carried out in the candidate’s country of origin will be considered. Only complete application files received at either of the following addresses before May 31st2014 will be submitted to the Scientific Committee: Secrétariat général de la Fondation La Roche-Posay Direction de la Communication Médicale 110, avenue Henri-Barbusse 92602 Asnières Cedex, France |
Information: | http://www.fondationlarocheposay@dca.loreal.com |
If you have anything to add into this section please e-mail the information you want to include to agneta[at]medicaljournals.se.